Jorge Mestre-Ferrandiz

10PUBLICATIONS
26CO-AUTHORS
Health and ecological risk assessmentApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Economic development policyClinical pharmacology and therapeuticsEconomic models and forecasting
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jan 13, 2026
Transferable Exclusivity Extension Vouchers for Antimicrobials: Incentive Design, Implementation Challenges, and Policy Trade-Offs.

Mario García-Díaz, Jorge Mestre-Ferrándiz, Jaime Espín

|Aug 08, 2025
A Framework for Considering the Role of the Public Sector in R&D of Health Technology.

Juan Carlos Rejon-Parrilla, David Epstein, Jorge Mestre-Ferrandiz

|Jan 12, 2024
A Review of Current Approaches to Evaluating and Reimbursing New Medicines in a Subset of OECD Countries.

Néboa Zozaya, Javier Villaseca, Irene Fernández

|Aug 09, 2021
How Much Does It Cost to Research and Develop a New Drug? A Systematic Review and Assessment.

Michael Schlander, Karla Hernandez-Villafuerte, Chih-Yuan Cheng

|Mar 24, 2020
Authors' Reply to Hays: "A Multinational European Study of Patient Preferences for Novel Diagnostics to Manage Antimicrobial Resistance".

David J Mott, Grace Hampson, Martin J Llewelyn

Pageof 2